• JNJ-26854165 (Serdemetan): HDM2 Antagonist for Cancer Resear

  2026-05-03

  JNJ-26854165 (Serdemetan) is a selective HDM2 ubiquitin ligase antagonist that stabilizes p53 and induces anti-proliferative and apoptosis effects in p53 wild-type cancer models. Its defined potency and in vivo radiosensitization properties make it a pivotal tool for mechanistic cancer research and drug response evaluation.

• Lipid Nanoparticle Structure Directs mRNA Delivery in Pregna

  2026-05-02

  This study elucidates how lipid nanoparticle composition and delivery route critically govern mRNA therapeutic potency and immunogenicity in pregnant models. Findings offer mechanistic guidance for designing safer, more effective RNA-based interventions for maternal health, addressing longstanding challenges in therapeutic delivery during pregnancy.

• Vacuolin-1 in Lysosomal Exocytosis: Beyond Inhibition to Pat

  2026-05-02

  Explore how Vacuolin-1, a leading lysosomal exocytosis inhibitor, uniquely advances our understanding of calcium-dependent membrane dynamics and disease modeling. This article reveals new assay design strategies and translational insights for researchers.

• Praeruptorin A Suppresses NF-κB and Inflammation in Poly (I:

  2026-05-01

  This study demonstrates that Praeruptorin A, a natural coumarin, inhibits NF-κB pathway activation and key inflammatory mediators in poly (I:C)-induced RAW264.7 macrophages. The findings clarify mechanisms of anti-inflammatory activity and highlight the value of RNA-seq for dissecting drug action in inflammation models.

• Oseltamivir Acid: Influenza Neuraminidase Inhibitor in Resea

  2026-04-30

  Oseltamivir acid stands out as a potent influenza neuraminidase inhibitor, offering translational value for both influenza antiviral research and emerging oncology models. This article details optimized workflows, practical troubleshooting, and key innovations that empower researchers to maximize experimental precision with APExBIO’s high-quality Oseltamivir acid.

• AG-221 (Enasidenib) for IDH2-Mutant AML: Protocols & Pitfall

  2026-04-30

  AG-221 (Enasidenib) empowers acute myeloid leukemia research by enabling precise, robust inhibition of mutant IDH2 and facilitating 2-hydroxyglutarate reduction. This guide translates the latest metabolic insights and reference findings into actionable workflows, troubleshooting tips, and assay enhancements for hematologic malignancies with IDH2 mutations.

• CUDC-907: Protocol Guidance for Dual PI3K and HDAC Inhibitio

  2026-04-29

  CUDC-907 provides a dual PI3K and HDAC inhibitor for in vitro cancer research workflows involving cell signaling, cell cycle, and apoptosis assays. It is not suitable for diagnostic or therapeutic use and should be applied strictly in controlled laboratory settings.

• Optimizing S-Phase Analysis with EdU Flow Cytometry Assay Ki

  2026-04-29

  EdU Flow Cytometry Assay Kits (Cy5) enable sensitive, denaturation-free quantification of S-phase DNA synthesis via click chemistry. This product is ideal for researchers requiring high specificity and compatibility with multiplexed fluorescence assays, but is not suitable for workflows needing DNA denaturation or alternative fluorophores.

• U 46619 in Renal and Platelet Research: Mechanistic Depth &

  2026-04-28

  Explore the multifaceted role of U 46619, a selective prostaglandin H2 analogue, in dissecting platelet aggregation and renal vascular responses. This article goes beyond standard workflows, integrating advanced mechanistic understanding and the latest reference findings to guide innovative assay design.

• Coronavirus Macrodomain Counters PARP-Mediated Antiviral Res

  2026-04-28

  This study demonstrates that the coronavirus macrodomain is essential for overcoming PARP-mediated inhibition of viral replication and the enhancement of interferon responses. The findings clarify the antiviral roles of PARP12 and PARP14, providing new insight into host-virus interactions relevant for antiviral strategy design.

• Ouabain: Selective Na⁺/K⁺-ATPase Inhibitor in Translational

  2026-04-27

  Ouabain, a highly selective Na⁺/K⁺-ATPase inhibitor, empowers researchers to dissect ion transport mechanisms and cardiovascular physiology with unparalleled precision. Explore stepwise experimental workflows, troubleshooting insights, and evidence-driven recommendations for maximizing data reliability in both in vitro and animal model studies.

• ALOX5 Deficiency Drives Ferroptosis Escape in Bladder Cancer

  2026-04-27

  This study uncovers ALOX5 deficiency as a critical mechanism for ferroptosis resistance in advanced bladder cancer, linking it to poor prognosis. The findings highlight ALOX5 as both a potential therapeutic target and prognostic biomarker, advancing the molecular understanding of bladder cancer progression.

• Pravastatin Sodium: Applied Workflows for HMG-CoA Reductase

  2026-04-26

  Harness the selective power of Pravastatin sodium for precise cholesterol biosynthesis inhibition and LDL reduction in translational and cardiovascular models. This article delivers actionable protocol enhancements, troubleshooting strategies, and evidence-based guidance—backed by APExBIO quality and the latest research on cellular and transporter interplay.

• Cy5 TSA Fluorescence System Kit: Precision Signal Amplificat

  2026-04-25

  The Cy5 TSA Fluorescence System Kit empowers researchers to achieve ultra-sensitive detection of low-abundance targets in immunohistochemistry, in situ hybridization, and immunocytochemistry. Leveraging horseradish peroxidase catalyzed tyramide deposition, it provides quantifiable improvements in sensitivity and workflow efficiency, as showcased in cardiovascular and neurobiological research.

• KN-62: Precision CaMKII Inhibition for Calcium Signaling Stu

  2026-04-24

  KN-62 delivers robust, selective inhibition of CaMKII, enabling reproducible modulation of calcium-dependent signaling and cell cycle arrest. This guide details practical workflows, troubleshooting, and application insights that help researchers maximize data quality using APExBIO’s KN-62, 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosy]-4-phenylpiperazine.

16739 records 1/1116 page Next 12345 下5页 Last page